scispace - formally typeset
S

Silvia Miretti

Researcher at University of Turin

Publications -  36
Citations -  755

Silvia Miretti is an academic researcher from University of Turin. The author has contributed to research in topics: Stem cell & Hepatocyte growth factor. The author has an hindex of 15, co-authored 35 publications receiving 644 citations.

Papers
More filters
Journal ArticleDOI

Validation of Met as a Therapeutic Target in Alveolar and Embryonal Rhabdomyosarcoma

TL;DR: The data show that both ARMS- and ERMS-derived cell lines seem to have retained an "addiction" to the Met oncogene and suggest that Met may represent a target of choice to develop novel therapeutic strategies for ARMS.
Journal ArticleDOI

A mouse model of pulmonary metastasis from spontaneous osteosarcoma monitored in vivo by Luciferase imaging.

TL;DR: This OSA animal model faithfully recapitulates some of the most important features of the human malignancy, such as lung metastatization, and the non-invasive imaging allows monitoring the tumor progression in living mice.
Journal ArticleDOI

Effects of stocking density and environmental enrichment on behavior and fecal corticosteroid levels of pigs under commercial farm conditions

TL;DR: The reduction of stocking density modified the pigs' behaviors and reduced the fecal corticosteroid levels, highlighting an improvement of welfare conditions.
Journal ArticleDOI

Functional effect of mir-27b on myostatin expression: a relationship in piedmontese cattle with double-muscled phenotype

TL;DR: It is demonstrated that bovine MSTN is a specific target of miR-27b and that miRNAs contribute to explain additive phenotypic hypertrophy in Piedmontese cattle selected for the MSTn gene mutation, possibly outlining a more precise genetic signature able to elucidate differences in muscle conformation.
Journal ArticleDOI

met oncogene activation qualifies spontaneous canine osteosarcoma as a suitable pre‐clinical model of human osteosarcoma

TL;DR: It is suggested that Met is commonly overexpressed and activated in canine OSA and that inhibition of Met impairs the invasive and motogenic properties of canine Oosarcoma cells.